Onycho Pharma has acquired rights for Amycot® in the USA and will conduct a clinical trial program to permit out-license of product for commercialisation as a prescription medicine. Amycot® is a highly efficacious natural treatment to manage onychomycosis using a patented bioactive extract from the cyanobacteria strain Arthrospira maxima. Our product is a addressing a a massively undertreated and rapidly growing market. Early clinical data (>100 patients) for this new topical treatment suggest: - Mycological and clinical cure rates >70% - No adverse treatment related effects and simple topical administration